Three years ago, Roche Pharmaceuticals faced a familiar but daunting challenge: 60,000 users across disconnected Atlassian instances, no standardised platform, and one of the most regulated operating environments in the world.

Hear how they embarked on a journey to consolidate that sprawl into a single, governed Cloud Enterprise platform — spanning medical device development, digital medicine, and pharma R&D. Learn how they designed for user diversity at scale, maintained GxP compliance throughout, and sequenced adoption from core Jira and Confluence through to Jira Product Discovery and Rovo.

Key takeaways:

• How to consolidate multi-instance sprawl into a single, governed Cloud Enterprise platform
• A framework for designing a cloud environment that serves diverse user needs across regulated and non-regulated teams
• How to sequence adoption to deliver value at every stage of a multi-year migration